Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,588
Sort by:
Atherosclerosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
268 pages
Corneal Neovascularization - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Corneal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
43 pages
Eosinophilic Esophagitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Eosinophilic Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
151 pages
Hepatitis D - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatitis D (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
102 pages
Yellow Fever - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
71 pages
Ureter Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ureter Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ureter Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
363 pages
Kidney Fibrosis - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
187 pages
Measles - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Measles (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Measles and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
49 pages
Optic Neuritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Optic Neuritis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
54 pages
Peanut Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
170 pages
Rotavirus Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
58 pages
Bone Metastasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bone Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
124 pages
Klebsiella pneumoniae Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
140 pages
Hairy Cell Leukemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hairy Cell Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hairy Cell Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
137 pages
Acinetobacter Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acinetobacter Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
204 pages
Haemophilus influenzae Type B Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Haemophilus influenzae Type B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Haemophilus influenzae Type B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
72 pages
Low Back Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
138 pages
Neurofibromatoses Type II - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neurofibromatoses Type II (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type II and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
62 pages
Binge Eating Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
48 pages
Narcolepsy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
100 pages
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
90 pages
Epidermolysis Bullosa - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Epidermolysis Bullosa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
170 pages
Neisseria meningitidis Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neisseria meningitidis Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
95 pages
Cataract - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
46 pages
Inclusion Body Myositis (IBM) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
73 pages
Guillain-Barre Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Guillain-Barre Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
84 pages
Epigenetics Market by Product (Kits, Reagents, Enzymes, and Instruments), Application (Oncology and Non-Oncology), and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
... of emerging markets provides lucrative opportunities to the market players. The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits ...
October 2020
291 pages
Chikungunya Fever - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
132 pages
Kidney Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Kidney Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
191 pages
Rett Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Rett Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
178 pages
Hepatitis A - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
34 pages
Behcet Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Behcet Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
68 pages
Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypertrophic Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertrophic Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
102 pages
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2020
US$ 2,500.00
... -Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
94 pages
Ventricular Tachycardia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ventricular Tachycardia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ventricular Tachycardia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
47 pages
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
57 pages
Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H2 2020
US$ 3,500.00
... Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
October 2020
56 pages
Parkinson's Disease - Pipeline Review, H2 2020
US$ 2,500.00
Parkinson's Disease - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Pipeline Review, H2 2020, provides an o...
October 2020
1308 pages
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 SUMMARY 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - The 5-HT6 receptor is a subtype of 5-HT receptor that binds t...
October 2020
62 pages
Cathepsin B - Pipeline Review, H2 2020
US$ 3,500.00
Cathepsin B - Pipeline Review, H2 2020 SUMMARY Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecul...
October 2020
33 pages
Cathepsin L1 - Pipeline Review, H2 2020
US$ 3,500.00
Cathepsin L1 - Pipeline Review, H2 2020 SUMMARY Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like fam...
October 2020
36 pages
Coagulation Factor XI - Pipeline Review, H2 2020
US$ 3,500.00
Coagulation Factor XI - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Coagulation Factor XI - Pipeline Review, H2 2020'; Coagulation Factor XI (Plasma Thromboplastin Ant...
October 2020
71 pages
Collagenase 3 - Pipeline Review, H2 2020
US$ 3,500.00
Collagenase 3 - Pipeline Review, H2 2020 SUMMARY Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 molec...
October 2020
62 pages
Estrogen Receptor Beta - Pipeline Review, H2 2020
US$ 3,500.00
Estrogen Receptor Beta - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Pipeline Review, H2 2020'; Estrogen Receptor Beta (ER Beta or Nuclear Rec...
October 2020
79 pages
Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020
US$ 3,500.00
Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020 SUMMARY Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Free fatty acid receptor 1 (FFA1), also known as GPR40, is...
October 2020
69 pages
